Health and Fitness Health and Fitness
Wed, June 20, 2012
[ Wed, Jun 20th 2012 ] - Market Wire
University of North Texas Health Science Center A .. Investing in Semiconductor DNA Sequencing Technol
[ Wed, Jun 20th 2012 ] - Market Wire
Life Technologies to Collaborate with Boston Chil .. Optimized Lab Workflow based on the Ion Protona"
[ Wed, Jun 20th 2012 ] - Market Wire
AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms
[ Wed, Jun 20th 2012 ] - Market Wire
Stellar Pharmaceuticals Acquires the Exclusive Rights to Collatamp G(R) in Canada
[ Wed, Jun 20th 2012 ] - Market Wire
InterMune Completes Divestiture of Actimmune (interferon gamma-1b)
[ Wed, Jun 20th 2012 ] - Market Wire
Implant Sciences Adds Former TSA Senior Executive Mo McGowan as Advisor
[ Wed, Jun 20th 2012 ] - Market Wire
Abbott Again Named One of the Best Workplaces in Europe
Tue, June 19, 2012
[ Tue, Jun 19th 2012 ] - Market Wire
BioSyent Pharma Secures Two Long-Term Hospital Su .. cts for Cathejell(TM) Jelly 2%-Shipments Commence
[ Tue, Jun 19th 2012 ] - Market Wire
AspenBio Pharma Announces Pricing of Public Offering of 6,100,000 Shares of Common Stock
[ Tue, Jun 19th 2012 ] - Market Wire
HealthSouth Corporation Signs Letter Of Intent To .. bilitation Unit Of CHRISTUS Santa Rosa Hospital -
[ Tue, Jun 19th 2012 ] - Market Wire
Cytokinetics Announces Proposed Public Offerings .. and Series B Convertible Preferred Stock and Warr
[ Tue, Jun 19th 2012 ] - Market Wire
Cytokinetics, Incorporated Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
[ Tue, Jun 19th 2012 ] - Market Wire
Onyx Pharmaceuticals to Hold Conference Call on J .. Advisory Committee Recommendation for Kyprolisa"
[ Tue, Jun 19th 2012 ] - Market Wire
Patient Home Monitoring (PHM) Announces Monthly Progress Report for May 2012
[ Tue, Jun 19th 2012 ] - Market Wire
MyHealthDIRECT Strengthens Board of Directors, Wins HHS Innovation Award
[ Tue, Jun 19th 2012 ] - Market Wire
InternetArray Subsidiary Noobis Reports Increased Sales Margins and New Releases
[ Tue, Jun 19th 2012 ] - Market Wire
Enzon Announces Data From Phase I Study of PEG-SN .. and Other Solid Tumors Presented at 2012 Advance
[ Tue, Jun 19th 2012 ] - Market Wire
XTL Biopharmaceuticals to Acquire Kitov Pharmaceuticals
[ Tue, Jun 19th 2012 ] - Market Wire
Chembio Diagnostics Announces Positive Data From .. oint-of-Care Hepatitis C Test Published in the Jo
[ Tue, Jun 19th 2012 ] - Market Wire
Cytomedix Announces Participation at 2012 BIO International Convention
[ Tue, Jun 19th 2012 ] - Market Wire
Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
[ Tue, Jun 19th 2012 ] - Market Wire
Ki Yong Choi Sends Letter to Cryo-Cell Stockholders
[ Tue, Jun 19th 2012 ] - Market Wire
Concerns of a Global Recession Haven't Held Back Booming Biotech Industry
[ Tue, Jun 19th 2012 ] - Market Wire
Biotech Industry Showing Investors Impressive Gains in 2012
[ Tue, Jun 19th 2012 ] - Market Wire
Equity Research on DaVita Inc. and HEALTHSOUTH Co .. -- Specialized Healthcare Companies Look to Grow
[ Tue, Jun 19th 2012 ] - Market Wire
ImmuCell Presents Strategic Overview at Annual Meeting of Stockholders
[ Tue, Jun 19th 2012 ] - Market Wire
ZYTO Corp Announces New Member to Scientific Advisory Board
[ Tue, Jun 19th 2012 ] - Market Wire
American Business Awards Honors MELA Sciences With Two Silver Stevie Awards
[ Tue, Jun 19th 2012 ] - Market Wire
Smith amp;; Nephew launches two plating sy .. kle surgeons at AOFAS annual meeting in San Diego
[ Tue, Jun 19th 2012 ] - Market Wire
Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations

Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations


Published on 2012-06-19 04:35:24 - Market Wire
  Print publication without navigation


Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations

Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies Allegations

[ ]

QUÉBEC CITY, June 19, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: [ AEZS ]) (TSX: AEZ) (the "Company") today announces that the Company has learned that two putative class action lawsuits have been filed against it alleging failures to disclose certain information under U.S. federal securities laws. The Company is in the process of reviewing the allegations, believes they are without merit and stands behind its continuous public disclosure record. Aeterna Zentaris believes that there is absolutely no basis for the lawsuits, and the Company intends to defend itself vigorously.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit [ www.aezsinc.com ].

SOURCE AETERNA ZENTARIS INC.

[ Back to top ]

Contributing Sources